Literature DB >> 5545116

On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog.

E Slatopolsky, S Caglar, J P Pennell, D D Taggart, J M Canterbury, E Reiss, N S Bricker.   

Abstract

Healthy adult dogs were subjected to stepwise reduction of nephron population so as to create the transition from normal renal function to advanced renal insufficiency. Studies were performed at each level of renal function. Glomerular filtration rate (GFR), renal phosphate clearance, and serum radioimmunoassayable parathyroid hormone (PTH) levels were measured. Two groups of animals were studied. In one, phosphorous intake was maintained at 1200 mg/day. As GFR declined, fractional phosphate excretion rose reciprocally, and PTH levels increased over 20-fold. In the second group, phosphorous intake was maintained at less than 100 mg/day. As GFR fell, fractional phosphate excretion changed little, and no increment in PTH levels occurred. The data suggest that the control system regulating phosphate excretion contributes importantly to the pathogenesis of secondary hyperparathyroidism in advancing renal insufficiency.

Entities:  

Mesh:

Year:  1971        PMID: 5545116      PMCID: PMC291955          DOI: 10.1172/JCI106517

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Chronic renal disease with secondary hyperparathyroidism.

Authors:  V E POLLAK; A F SCHNEIDER; G FREUND; R M KARK
Journal:  AMA Arch Intern Med       Date:  1959-02

2.  IMMUNOASSAY OF BOVINE AND HUMAN PARATHYROID HORMONE.

Authors:  S A Berson; R S Yalow; G D Aurbach; J T Potts
Journal:  Proc Natl Acad Sci U S A       Date:  1963-05       Impact factor: 11.205

Review 3.  Caclium, phosphorus, and bone in renal disease and transplantation.

Authors:  N S Bricker; E Slatopolsky; E Reiss; L V Avioli
Journal:  Arch Intern Med       Date:  1969-05

4.  Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate.

Authors:  L M Sherwood; G P Mayer; C F Ramberg; D S Kronfeld; G D Aurbach; J T Potts
Journal:  Endocrinology       Date:  1968-11       Impact factor: 4.736

5.  The role of phosphate in the secretion of parathyroid hormone in man.

Authors:  E Reiss; J M Canterbury; M A Bercovitz; E L Kaplan
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

6.  Application of radioimmunoassay to differentiation of adenoma and hyperplasia and to preoperative localization of hyperfunctioning parathyroid glands.

Authors:  E Reiss; J M Canterbury
Journal:  N Engl J Med       Date:  1969-06-19       Impact factor: 91.245

7.  Experience with a radioimmunoassay of parathyroid hormone in human sera.

Authors:  E Reiss; J M Canterbury; R H Egdahl
Journal:  Trans Assoc Am Physicians       Date:  1968

8.  Control of phosphate excretion in uremic man.

Authors:  E Slatopolsky; A M Robson; I Elkan; N S Bricker
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

9.  Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia, and bronchogenic carcinoma.

Authors:  S A Berson; R S Yalow
Journal:  Science       Date:  1966-11-18       Impact factor: 47.728

10.  Divalent ion metabolism and osteodystrophy in chronic renal failure.

Authors:  C R Kleeman; O Better; S G Massry; M H Maxwell
Journal:  Yale J Biol Med       Date:  1967-08-01
View more
  72 in total

Review 1.  Renal osteodystrophy.

Authors:  E A González; K J Martin
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

Review 2.  Hyperphosphataemia in renal failure: causes, consequences and current management.

Authors:  Fouad Albaaj; Alastair Hutchison
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Trabecular bone morphometry in beagles with chronic renal failure.

Authors:  R W Norrdin; P Bordier; C W Miller
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-09-28

Review 4.  FGF23 and PTH--double agents at the heart of CKD.

Authors:  Justin Silver; Mariano Rodriguez; Eduardo Slatopolsky
Journal:  Nephrol Dial Transplant       Date:  2012-03-23       Impact factor: 5.992

5.  Dissociation of renal cyclic AMP and phosphate responses to parathyroid hormone in uremia.

Authors:  J E Russell; M Kleerekoper; E Slatopolsky; J Lewis; S W Lee; L V Avioli
Journal:  Calcif Tissue Int       Date:  1979-11-26       Impact factor: 4.333

6.  [Surgical aspects of secondary hyperparathyroidism (author's transl)].

Authors:  H D Röher; R Wahl
Journal:  Langenbecks Arch Chir       Date:  1976-12-22

7.  The case for routine parathyroid hormone monitoring.

Authors:  Stuart M Sprague; Sharon M Moe
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-04       Impact factor: 8.237

8.  Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure.

Authors:  S Lopez-Hilker; T Galceran; Y L Chan; N Rapp; K J Martin; E Slatopolsky
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

9.  Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.

Authors:  T J Hahn; L R Halstead; S L Teitelbaum; B H Hahn
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

10.  Reversal of secondary hyperparathyroidism by cimetidine in chronically uremic dogs.

Authors:  A I Jacob; J M Canterbury; G Gavellas; P W Lambert; J J Bourgoignie
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.